Skip to main content

Cancer Biomarker Discovery via Low Molecular Weight Serum Proteome Profiling - Where Is the Tumor?

Davis M T, Auger P, Spahr C, Patterson S D

Publication: Proteomics Clin Appl (2007) • Vol 1 • Page 1545

Purpose

The purpose of this paper was to determine the impact coagulation activation (induced via room temperature storage for 0-120 min) has on low molecular weight (<20 kDa) proteome patterns of blood specimens, which are under scrutiny as potential biomarkers for cancer screening.

Conclusion

The authors conclude that differential proteome patterns reportedly associated with disease state are a result of disregulated hemostasis and can be observed in normal serum specimens as soon as 30 minutes post collection; thus, the reported correlation between low molecular weight biomarker pattern and disease state is a temporal one. Also of note, analysis of plasma generated less complex results than serum for in-house studies, but was equally variable when specimens were collected via a contracted clinic.

Studies (2)

Purpose

The purpose of this study was to compare low molecular weight proteome patterns of paired serum and plasma samples collected from healthy and newly diagnosed prostate cancer patients at two collection centers.

Summary of Findings

Paired serum and plasma specimens were qualitatively different when analyzed by SELDI-TOF MS 30 minutes after blood collection, with multiple peaks unique to serum specimens observed that were later identified as fibrinopeptide A derivatives, indicating activation of the intrinsic coagulation cascade. Of note, comparison of serum and plasma samples collected via a secondary collection center yielded spectral complexity greater than predicted by the initial "in-house" study, although peaks were still consistent with products generated by the coagulation pathway for both serum and plasma samples.

  • Biospecimens

    FluidSerum
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
    NeoplasticCarcinoma
  • Platforms

    ProteinSELDI-TOF MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum